SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-021868
Filing Date
2022-11-03
Accepted
2022-11-03 16:11:23
Documents
14
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlay-20221103.htm   iXBRL 8-K 61513
2 EX-99.1 rlay-ex99_1.htm EX-99.1 256190
3 GRAPHIC img175089203_0.jpg GRAPHIC 7375
  Complete submission text file 0000950170-22-021868.txt   458175

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20221103_pre.xml EX-101.PRE 10994
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20221103_lab.xml EX-101.LAB 13474
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20221103.xsd EX-101.SCH 2459
8 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20221103_htm.xml XML 4764
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 221358101
SIC: 2836 Biological Products, (No Diagnostic Substances)